Philipp Ruile

Philipp Ruile

Auto-generated profile, based on publicly available information

Philipp Ruile

Department of Cardiology & Angiology II, University Heart Center Freiburg-Bad Krozingen, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Radiology
Verified
Journal Article
Closed access
MHMuhammad Taha Hagar
Muhammad Taha Hagar
MSMartin Soschynski
Martin Soschynski
RSRuben Saffar
Ruben Saffar
ARAlexander Rau
Alexander Rau
JTJana Taron
Jana Taron
TKTobias Krauss
Tobias Krauss
Background Recently introduced photon-counting CT may improve noninvasive assessment of patients with high risk for coronary artery disease (CAD). Purpose To determine the diagnostic accuracy of ultrahigh-resolution (UHR) coronary CT angiography (CCTA) in the detection of CAD compared with the reference standard of invasive coronary angiography (ICA). Materials and Methods In this prospective study, participants with severe aortic valve stenosis and clinically indicated CT for transcatheter aortic valve replacement planning were consecutively enrolled from August 2022 to February 2023. All participants were examined with a dual-source photon-counting CT scanner using a retrospective electrocardiography-gated contrast-enhanced UHR scanning protocol (tube voltage, 120 or 140 kV; collimation, 120 × 0.2 mm; 100 mL of iopromid; no spectral information). Subjects underwent ICA as part of their clinical routine. A consensus assessment of image quality (five-point Likert scale: 1 = excellent [absence of artifacts], 5 = nondiagnostic [severe artifacts]) and a blinded independent reading for the presence of CAD (stenosis ≥50%) were performed. UHR CCTA was compared with ICA using area under the receiver operating characteristic curve (AUC). Results Among 68 participants (mean age, 81 years ± 7 [SD]; 32 male, 36 female), the prevalence of CAD and prior stent placement was 35% and 22%, respectively. The overall image quality was excellent (median score, 1.5 [IQR, 1.3-2.0]). The AUC of UHR CCTA in the detection of CAD was 0.93 per participant (95% CI: 0.86, 0.99), 0.94 per vessel (95% CI: 0.91, 0.98), and 0.92 per segment (95% CI: 0.87, 0.97). Sensitivity, specificity, and accuracy, respectively, were 96%, 84%, and 88% per participant (n = 68); 89%, 91%, and 91% per vessel (n = 204); and 77%, 95%, and 95% per segment (n = 965). Conclusion UHR photon-counting CCTA provided high diagnostic accuracy in the detection of CAD in a high-risk population, including subjects with severe coronary calcification or prior stent placement. Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Williams and Newby in this issue.

4 September 2019 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
AAAdrian Attinger‐Toller
Adrian Attinger‐Toller
RBRahul Bhindi
Rahul Bhindi
GPGidon Y. Perlman
Gidon Y. Perlman
DMDale Murdoch
Dale Murdoch
JWJonathan Weir‐McCall
Jonathan Weir‐McCall
JWJohn G. Webb
John G. Webb

6 November 2017 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SSSimon Schoechlin
Simon Schoechlin
TBTim Brennemann
Tim Brennemann
AAAbdelhakim Allali
Abdelhakim Allali
PRPhilip Ruile
Philip Ruile
NJNikolaus Jander
Nikolaus Jander
MAMohamed Abdel‐Wahab
Mohamed Abdel‐Wahab

6 July 2023 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MSMartin Soschynski
Martin Soschynski
MHManuel Hein
Manuel Hein
FCFabio Capilli
Fabio Capilli
MHMuhammad Taha Hagar
Muhammad Taha Hagar
PRPhilipp Ruile
Philipp Ruile
TKTobias Krauss
Tobias Krauss
Aims: To determine the conditions under which early hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) becomes haemodynamically relevant. Methods and results: The study included 100 patients (age: 81.5 ± 5.5 years; female 63%), thereof 50 patients with HALT. After anonymization and randomization, blinded readers measured maximum thrombus thickness per prosthesis (MT_pr) and movement restriction (MR_pr) on electrocardiogram (ECG)-gated whole heart cycle computed tomography angiography. These measurements were compared with echocardiographic mean pressure gradient (mPG), its increase from baseline (ΔmPG), and Doppler velocity index (DVI). Haemodynamic valve deterioration (HVD) was defined as mPG > 20 mmHg. Age, body mass index, valve type, valve size, left ventricular ejection fraction, and atrial fibrillation were considered as influencing factors. Multiple regression analysis revealed that only valve size (P = 0.001) and MT_pr (P = 0.02) had a significant influence on mPG. In an interaction model, valve size moderated the effect of MT_pr on mPG significantly (P = 0.004). Sub-group analysis stratified by valve sizes showed a strong correlation between MT_pr and echocardiographic parameters for 23 mm valves (mPG: r = 0.57, ΔmPG: r = 0.68, DVI: r = 0.55, each with P < 0.001), but neither for 26 nor 29 mm valves (r < 0.2, P > 0.2 for all correlations). Six of seven prostheses with HVD had a 23 mm valve diameter, while one had 29 mm (P = 0.02). Conclusion: Early HALT rarely causes significant mPG increase. Our study shows that valve size is a key factor influencing the haemodynamic impact of HALT. In small valve sizes, mPG is more likely to increase. Our study is the first to offer in vivo evidence supporting previous in vitro findings on this topic.

1 February 2023 in European Heart Journal - Case Reports
Verified
Journal Article
Open access
PDF file
FSFlorian Seiler
Florian Seiler
PRPhilipp Ruile
Philipp Ruile
MMMartin Moser
Martin Moser
THThomas Helbing
Thomas Helbing
The point mutation at position 3243 in the mitochondrial MT-TL1 gene (m.3243A > G) is a rare cause of hypertrophic cardiomyopathy (HCM). Information about HCM progression over time and occurrence of different cardiomyopathies in m.3243A > G carriers of the same family is still lacking. A 48-year old male patient was admitted to a tertiary care hospital with chest pain and dyspnea. Bilateral hearing loss required hearing aids at the age of 40. A short PQ interval, narrow QRS complex and inverted T-waves in lateral leads were present on electrocardiogram. HbA1c of 7.3 mmol/L indicated prediabetes. Echocardiography excluded valvular heart disease and detected non-obstructive hypertrophic cardiomyopathy with slightly reduced left ventricular ejection fraction (LVEF 48%). Coronary artery disease was ruled out by coronary angiography. Myocardial fibrosis determined by repeated cardiac MRI progressed over time. Endomyocardial biopsy excluded storage disease, Fabry disease, infiltrative and inflammatory cardiac disease. Genetic testing revealed m.3243A > G mutation in the MT-TL1 gene associated with mitochondrial disease. Clinical evaluation and genetic testing of the patients’ family revealed five genotype-positive relatives with heterogeneous clinical phenotypes including deafness, diabetes mellitus, kidney disease and both hypertrophic and dilated cardiomyopathy. In patients with unexplained symmetric HCM with heterogenic clinical phenotypes at the organ levels mitochondrial disease should be taken into consideration, particularly in the context of matrilinear transmission. m.3243A > G mutation is associated with a mitochondrial disease in the index patient and five family members and leads to the diagnosis of maternal inherited diabetes and deafness (MIDD) with intra-familial variability of different cardiomyopathy forms.

17 September 2018 in JACC
Verified
Journal Article
Closed access
PDF file
CDCameron Dowling
Cameron Dowling
ABAlessandra Bavo
Alessandra Bavo
PMPeter Mortier
Peter Mortier
NFNahid El Faquir
Nahid El Faquir
PJPeter de Jaegere
Peter de Jaegere
SBStephen Brecker
Stephen Brecker